142 related articles for article (PubMed ID: 37855715)
1. Plasma Extracellular Vesicle LncRNA H19 as a Potential Diagnostic Biomarker for Inflammatory Bowel Diseases.
Heydari R; Fayazzadeh S; Shahrokh S; Shekari F; Farsad F; Meyfour A
Inflamm Bowel Dis; 2024 May; 30(5):795-807. PubMed ID: 37855715
[TBL] [Abstract][Full Text] [Related]
2. Serum long noncoding RNA H19/micro RNA-675-5p axis as a probable diagnostic biomarker in inflammatory bowel disease.
Shaker OG; Safa A; Khairy A; Abozeid NF
Mol Biol Rep; 2023 Nov; 50(11):9029-9036. PubMed ID: 37716920
[TBL] [Abstract][Full Text] [Related]
3. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
4. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
[TBL] [Abstract][Full Text] [Related]
5. Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective.
Wasinger VC; Yau Y; Duo X; Zeng M; Campbell B; Shin S; Luber R; Redmond D; Leong RW
Mol Cell Proteomics; 2016 Jan; 15(1):256-65. PubMed ID: 26530476
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNAs and circular RNAs as potential diagnostic biomarkers of inflammatory bowel diseases: a systematic review and meta-analysis.
Belete MA; Tadesse S; Tilahun M; Gedefie A; Shibabaw A; Mulatie Z; Wudu MA; Gebremichael S; Debash H; Alebachew M; Alemayehu E
Front Immunol; 2024; 15():1362437. PubMed ID: 38524131
[TBL] [Abstract][Full Text] [Related]
7. Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease.
Hisamatsu T; Okamoto S; Hashimoto M; Muramatsu T; Andou A; Uo M; Kitazume MT; Matsuoka K; Yajima T; Inoue N; Kanai T; Ogata H; Iwao Y; Yamakado M; Sakai R; Ono N; Ando T; Suzuki M; Hibi T
PLoS One; 2012; 7(1):e31131. PubMed ID: 22303484
[TBL] [Abstract][Full Text] [Related]
8. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
[TBL] [Abstract][Full Text] [Related]
9. Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome.
Manolakis AC; Kapsoritakis AN; Georgoulias P; Tzavara C; Valotassiou V; Kapsoritaki A; Potamianos SP
BMC Gastroenterol; 2010 Oct; 10():118. PubMed ID: 20946669
[TBL] [Abstract][Full Text] [Related]
10. Expression profile of serum LncRNA THRIL and MiR-125b in inflammatory bowel disease.
Elamir A; Shaker O; Kamal M; Khalefa A; Abdelwahed M; Abd El Reheem F; Ahmed T; Hassan E; Ayoub S
PLoS One; 2022; 17(10):e0275267. PubMed ID: 36206229
[TBL] [Abstract][Full Text] [Related]
11. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D
Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
[TBL] [Abstract][Full Text] [Related]
12. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
Dawiskiba T; Deja S; Mulak A; Ząbek A; Jawień E; Pawełka D; Banasik M; Mastalerz-Migas A; Balcerzak W; Kaliszewski K; Skóra J; Barć P; Korta K; Pormańczuk K; Szyber P; Litarski A; Młynarz P
World J Gastroenterol; 2014 Jan; 20(1):163-74. PubMed ID: 24415869
[TBL] [Abstract][Full Text] [Related]
13. Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression.
Perera LP; Radigan M; Guilday C; Banerjee I; Eastwood D; Babygirija R; Massey BT
Dig Dis Sci; 2019 Jul; 64(7):1923-1928. PubMed ID: 30725303
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study.
Zissimopoulos A; Vradelis S; Konialis M; Chadolias D; Bampali A; Constantinidis T; Efremidou E; Kouklakis G
Scand J Gastroenterol; 2014 Aug; 49(8):942-9. PubMed ID: 24897131
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity.
Oikonomou KA; Kapsoritakis AN; Theodoridou C; Karangelis D; Germenis A; Stefanidis I; Potamianos SP
J Gastroenterol; 2012 May; 47(5):519-30. PubMed ID: 22200942
[TBL] [Abstract][Full Text] [Related]
16. Differential expressions and potential clinical values of lncRNAs in the plasma exosomes of rheumatoid arthritis.
Shuai ZQ; Wang ZX; Ren JL; Yang XK; Xu B
Int Immunopharmacol; 2024 Feb; 128():111511. PubMed ID: 38194746
[TBL] [Abstract][Full Text] [Related]
17. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
[TBL] [Abstract][Full Text] [Related]
18. The Origin of Plasma-Derived Bacterial Extracellular Vesicles in Healthy Individuals and Patients with Inflammatory Bowel Disease: A Pilot Study.
Jones E; Stentz R; Telatin A; Savva GM; Booth C; Baker D; Rudder S; Knight SC; Noble A; Carding SR
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681030
[TBL] [Abstract][Full Text] [Related]
19. Serum ST2 in inflammatory bowel disease: a potential biomarker for disease activity.
Boga S; Alkim H; Koksal AR; Ozagari AA; Bayram M; Tekin Neijmann S; Sen I; Alkim C
J Investig Med; 2016 Jun; 64(5):1016-24. PubMed ID: 27001944
[TBL] [Abstract][Full Text] [Related]
20. The central role of psychopathology and its association with disease severity in inflammatory bowel disease and irritable bowel syndrome.
Piacentino D; Cesarini M; Badiali D; Pallotta N; Biondi M; Corazziari ES
Riv Psichiatr; 2019; 54(2):75-83. PubMed ID: 30985832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
